Our founder, Jung Joo Moon, M.D., is the inventor on a portfolio of molecular and rapid diagnostic technologies developed since 2021.
A lateral-flow test strip for detecting SARS-CoV-2 antigen.
Granted patent in the Republic of Korea (2026); U.S. application under examination. Priority from 2021.
Primer, probe and DNA-chip methods for detecting and genotyping SARS-CoV-2.
U.S. application pending, from an international (PCT) application filed in 2022.
Primers and probes for identifying SARS-CoV-2 variants of concern and for detecting cancer-related gene mutations.
U.S. application pending (filed 2024).
Patent numbers are available on request.
